| 000 | 01455 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516191850.0 | ||
| 264 | 0 | _c20150708 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a2040-2058 | ||
| 024 | 7 |
_a10.3851/IMP2728 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbbas, Zaigham | |
| 245 | 0 | 0 |
_aTreatment of chronic hepatitis D patients with pegylated interferon: a real-world experience. _h[electronic resource] |
| 260 |
_bAntiviral therapy _c2014 |
||
| 300 |
_a463-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis D, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis Delta Virus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
| 650 | 0 | 4 |
_aInterferons _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMemon, Mohammad S | |
| 700 | 1 | _aMithani, Hammad | |
| 700 | 1 | _aJafri, Wasim | |
| 700 | 1 | _aHamid, Saeed | |
| 773 | 0 |
_tAntiviral therapy _gvol. 19 _gno. 5 _gp. 463-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3851/IMP2728 _zAvailable from publisher's website |
| 999 |
_c23448058 _d23448058 |
||